Consumer Insights
Uncover trends and behaviors shaping consumer choices today
Procurement Insights
Optimize your sourcing strategy with key market data
Industry Stats
Stay ahead with the latest trends and market analysis.
Simvastatin prices in Germany, the highest-cost reporting region, rose 2.0% in Q2 2026 to USD 204.00/KG from USD 200.00/KG in Q1, extending a modest recovery within this market's characteristically tight trading range. Indian prices, the factory-gate benchmark that anchors global export offers, rose 1.8% to USD 166.00/KG. Globally, the average rose from USD 178.44/KG in Q1 to USD 181.98/KG in Q2, a 2.0% gain, holding well within the roughly six-dollar band this market has occupied for the entire period covered in this report. For H2 2026, this market's forecast reads steady, with the projected band at USD 171.00-190.00/KG bracketing the current level as competition caps the upside and input costs floor the downside.
Simvastatin is a generic HMG-CoA reductase inhibitor, a statin-class active pharmaceutical ingredient used to lower cholesterol and reduce cardiovascular risk, produced through a fermentation process using a fungal strain followed by chemical semi-synthesis. As one of the earliest and most widely genericized statins, this market operates as a mature, high-volume commodity API where intense generic competition keeps pricing in a narrow band regardless of underlying feedstock cost swings. India hosts the fermentation and finishing capacity that supplies the global generics trade, and its factory-gate pricing anchors export offers for buyers worldwide. Fermentation and intermediate costs, generic competition intensity, and steady prescription demand from an aging population with rising cardiovascular disease prevalence are what drive prices in this market.
The outlook for Simvastatin through H2 2026 reads steady, with the projected band at USD 171.00-190.00/KG bracketing the current level. Intense generic competition continues capping the upside on any input cost pressure, while fermentation and intermediate costs provide a floor beneath which pricing rarely falls, a dynamic that has held consistently throughout the period covered in this report and is expected to persist through the remainder of the year.
The main upside risk is a tightening of fermentation feedstock or intermediate availability, or a consolidation among generic manufacturers reducing competitive pricing pressure, which could push this market toward the top of its projected band. The main downside risk is a further intensification of generic competition combined with softer prescription demand, which could pressure pricing toward the lower end of the forecast range.
| Region | 2026 Price Range (USD/KG) | Outlook |
| Global Average | 171.00 - 190.00 | Competition caps the upside, input costs floor the downside |
| Germany | 192.00 - 212.00 | Established European formulator base sustains the highest cost |
| United States | 183.00 - 202.00 | Steady cardiovascular prescription demand supports firmness |
| India | 156.00 - 172.00 | Factory-gate fermentation and finishing hub anchors export offers |
| China | 147.00 - 162.00 | Large-scale generic production keeps this the most affordable market |
German Simvastatin prices averaged USD 204.00/KG in Q2 2026, the highest of any region tracked here, up 2.0% from USD 200.00/KG in Q1, extending a modest recovery within this market's tight trading range.
Why did the price of Simvastatin change in Q2 2026 in Germany?
Steady demand from established European formulators, tied to cardiovascular prescription channels, continued keeping this market at the top of the range tracked in this report, even as intense generic competition kept the pace of gains modest.
US prices averaged USD 195.00/KG in Q2 2026, up 2.1% from USD 191.00/KG in Q1, tracking the broader modest recovery evident across the market.
Why did the price of Simvastatin change in Q2 2026 in United States?
Steady prescription demand from an aging population with rising cardiovascular disease prevalence continued supporting this market's recovery within its characteristically narrow band.
Indian prices, the factory-gate benchmark that anchors global export offers, averaged USD 166.00/KG in Q2 2026, up 1.8% from USD 163.00/KG in Q1.
Why did the price of Simvastatin change in Q2 2026 in India?
As the fermentation and finishing hub that supplies the global generics trade, this market's factory-gate pricing continued anchoring export offers worldwide, with modest gains tracking the broader recovery.
Chinese prices, the lowest of the four regions, averaged USD 156.00/KG in Q2 2026, up 2.0% from USD 153.00/KG in Q1, tracking the broader global recovery within this market's tight range.
Why did the price of Simvastatin change in Q2 2026 in China?
Large-scale generic API production capacity continued keeping Chinese offers the most competitive of any region tracked here, even as the broader market-wide recovery pushed prices modestly higher.
German prices rose 1.5% in Q1 2026 to USD 200.00/KG from USD 197.00/KG in Q4 2025, returning toward earlier 2025 levels.
Why did the price of Simvastatin change in Q1 2026 in Germany?
Global simvastatin prices held a tight band through 2025, with the average edging up before easing by Q4 and returning to roughly the Q1 2025 level in Q1 2026, the whole period fitting inside a narrow range as competition capped the upside and input costs floored the downside.
US prices rose 1.6% in Q1 2026 to USD 191.00/KG from USD 188.00/KG in Q4 2025, tracking the broader market-wide recovery.
Why did the price of Simvastatin change in Q1 2026 in United States?
Fermentation and intermediate costs, generic competition, regulatory compliance, steady prescription demand, and currency movements continued shaping this mature, high-volume commodity API market within its established narrow trading band.
Indian factory-gate prices rose 1.9% in Q1 2026 to USD 163.00/KG from USD 160.00/KG in Q4 2025, returning toward the level seen at the start of 2025.
Why did the price of Simvastatin change in Q1 2026 in India?
As the hub that hosts the fermentation and finishing capacity supplying the global generics trade, this market's factory-gate price continued anchoring export offers worldwide, tracking the broader market-wide return toward early-2025 levels.
Chinese prices rose 2.0% in Q1 2026 to USD 153.00/KG from USD 150.00/KG in Q4 2025, tracking the broader market-wide recovery.
Why did the price of Simvastatin change in Q1 2026 in China?
Steady, price-insensitive prescription demand provided a stable baseline even as intense generic competition continued keeping this market's pricing within its established narrow trading band.
Global Simvastatin prices held a genuinely tight band through every quarter tracked in this report, edging up modestly in Q2 2025 before easing through the back half of the year and returning to roughly the starting level by Q1 2026, with the entire period fitting inside a range of roughly ten dollars, a hallmark of this market's mature, highly genericized, competition-capped pricing structure.
| Quarter | Price (USD/KG) | QoQ Change | Direction |
| Q2 2026 | 181.98 | +2.0% | ↑ Rising |
| Q1 2026 | 178.44 | +1.7% | ↑ Rising |
| Q4 2025 | 175.44 | -1.4% | ↓ Falling |
| Q3 2025 | 177.98 | -3.7% | ↓ Falling |
| Q2 2025 | 184.80 | - | — Stable |
| Q3 2026 | In Progress | - | — In Progress |
Simvastatin eased modestly across every market covered in this report through 2025, staying within a tight band throughout, as intense generic competition capped any upward movement even as fermentation and intermediate costs prevented a sharper decline, before a modest recovery returned pricing to roughly its starting level in early 2026.
German prices eased from about USD 205.00/KG in Q1 2025 to USD 197.00/KG by Q4, down roughly 3.9%, within this market's characteristically tight trading range.
US prices eased from about USD 195.00/KG in Q1 2025 to USD 188.00/KG by Q4, down roughly 3.6%, tracking the broader tight-band pattern.
Indian factory-gate prices eased from about USD 165.00/KG in Q1 2025 to USD 160.00/KG by Q4, down roughly 3.0%, the smallest annual decline of the four regions.
Chinese prices eased from about USD 155.00/KG in Q1 2025 to USD 150.00/KG by Q4, down roughly 3.2%, tracking the broader tight-band pattern before the modest recovery that followed into 2026.
Expert Market Research: Your Source for Real-Time Simvastatin Price Intelligence
Expert Market Research tracks Simvastatin prices continuously across every major producing and consuming region, combining fermentation and intermediate cost data, generic competition intensity signals, and cardiovascular treatment prescription demand trends into a single, regularly updated view of the market. Our team can help your procurement function benchmark current offers, plan purchases around the tight-band trends covered in this report, and build a defensible view of where this essential cholesterol-lowering API is headed next. Reach out to our team for a tailored briefing or a deeper look at any of the regional markets covered here.
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*
It is a generic HMG-CoA reductase inhibitor, a statin-class active pharmaceutical ingredient used to lower cholesterol and reduce cardiovascular risk.
The Q2 2026 global average was USD 181.98/KG, ranging from USD 156.00/KG in China to USD 204.00/KG in Germany.
The global average rose from USD 175.44/KG in Q4 2025 to USD 178.44/KG in Q1 2026 and then to USD 181.98/KG in Q2, holding well within the roughly six-dollar band this market has occupied throughout the period covered in this report.
As one of the earliest and most widely genericized statins, this market operates as a mature, high-volume commodity API where intense generic competition keeps pricing in a narrow band, with competition capping the upside and fermentation and intermediate costs flooring the downside.
The forecast reads steady, with the projected band at USD 171.00-190.00/KG bracketing the current level.
China holds the lowest cost among the regions tracked here given large-scale generic production, while Germany carries the highest cost given its established European formulator base.
This report is updated monthly. For real-time pricing intelligence, connect with the Expert Market Research team.
Fermentation and intermediate costs, generic competition intensity, and steady prescription demand from an aging population with rising cardiovascular disease prevalence.
India hosts the fermentation and finishing capacity that supplies the global generics trade, with its factory-gate pricing anchoring export offers worldwide, while Germany, the United States, and China are also significant consuming markets.
Buyers can monitor Indian factory-gate pricing given its role anchoring global export offers, time forward purchases around the quarterly breakdowns in this report, and benchmark supplier quotes against the tracked price ranges given this market's characteristically narrow trading band.
One Year Subscription
One Year Subscription
USD 799
USD 699
tax inclusive*
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Small Business Bundle
Growth Bundle
Enterprise Bundle
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Number of Reports: 3
20%
tax inclusive*
Small Business Bundle
Number of Reports: 5
25%
tax inclusive*
Growth Bundle
Number of Reports: 8
30%
tax inclusive*
Enterprise Bundle
Number of Reports: 10
35%
tax inclusive*
How To Order
Select License Type
Choose the right license for your needs and access rights.
Click on ‘Buy Now’
Add the report to your cart with one click and proceed to register.
Select Mode of Payment
Choose a payment option for a secure checkout. You will be redirected accordingly.
Strategic Solutions for Informed Decision-Making
Gain insights to stay ahead and seize opportunities.
Get insights & trends for a competitive edge.
Track prices with detailed trend reports.
Analyse trade data for supply chain insights.
Leverage cost reports for smart savings
Enhance supply chain with partnerships.
Connect For More Information
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.
Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.
We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.